In summary, this study puts forward a potential mechanism of regulating ESCC malignant progression through the circCYP24A1/ PKM2/ NF-κB/ CCL5 pathway, which may provied a new approach and the therapeutic target for judging prognosis and therapy of ESCC. This evidence concerns the gene CCL5 and esophageal squamous cell carcinoma.